查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1758043

醫療保健領域區塊鏈的全球市場

Blockchain in Healthcare
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 216 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年，全球醫療保健區塊鏈市場規模將達到 130 億美元

全球醫療保健區塊鏈市場規模預計在2024年為12億美元，預計到2030年將達到130億美元，2024年至2030年的複合年成長率為49.0%。作為報告分析的細分市場之一，私有網路預計將實現51.8%的複合年成長率，並在分析期結束時達到104億美元。公共網路細分市場在分析期間內的複合年成長率預計為40.4%。

美國市場規模估計為 3.122 億美元，中國市場預計複合年成長率為 46.2%

美國醫療保健區塊鏈市場規模預計在2024年達到3.122億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到19億美元，在2024-2030年的分析期間內，複合年成長率為46.2%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為44.9%和41.9%。在歐洲，預計德國的複合年成長率約為33.2%。

全球醫療保健市場區塊鏈—主要趨勢和促進因素摘要

為什麼區塊鏈會成為醫療保健創新的基礎技術？

區塊鏈技術正迅速成為醫療保健領域的一股變革力量，有望解決醫療保健產業一些最持久的挑戰，包括資料碎片化、安全漏洞和管理流程低效。區塊鏈的核心在於提供一個去中心化、不可篡改的帳本，使不同的醫療保健相關人員能夠安全透明地共用資料。在病歷、保險理賠、臨床試驗和供應鏈資料通常各自為政、難以核對的環境下，這種獨特的能力尤其重要。透過實現對防篡改資訊的即時訪問，區塊鏈提高了資料完整性，並促進了傳統上無法無縫整合的系統之間的互通性。處理電子健康記錄(EHR) 時對網路安全和隱私日益成長的需求也是一個主要促進因素，而區塊鏈提供的端對端加密和檢驗的存取控制超越了現有標準。隨著數位醫療服務透過遠端醫療、穿戴式裝置和健康應用程式不斷發展，區塊鏈提供了一種解決方案，可以管理跨裝置生成和共用的敏感健康數據的激增。此外，政府和監管機構越來越意識到這項技術的潛力，全球範圍內啟動了試驗計畫和官民合作關係關係，以測試基於區塊鏈的醫療記錄管理、藥物可追溯性和同意處理應用。隨著信任和透明度成為醫療保健轉型的關鍵支柱，區塊鏈不僅僅是一種 IT 增強，而且是醫療保健服務新時代的根本推動者。

區塊鏈應用在不同醫療保健領域如何發展？

區塊鏈在醫療保健領域的應用範圍正在迅速擴展，其應用涵蓋多個領域，包括病患資料管理、藥品供應鏈、臨床試驗、保險和醫療服務提供者資格認證。在病歷領域，區塊鏈有助於創建由患者擁有和控制的縱向健康記錄，並可安全地與多家醫療服務提供者共用。這在跨專科和跨地區的慢性病管理和護理協調中尤其重要。在製藥業，區塊鏈正被用於打擊假藥，實現藥品從製造商到藥房的端到端可追溯性。這種透明度確保了藥品的真實性，減少了欺詐，並提高了藥品召回的效率。同樣，區塊鏈透過為方案、患者知情同意書和檢測結果提供不可篡改的時間戳數據，提高了臨床試驗的完整性。在保險業，智慧合約正在簡化理賠流程，實現核准和支付的自動化，同時降低詐欺和管理成本。同時，醫療保健機構開始使用區塊鏈即時檢驗醫療服務提供者的資格和執照，從而加快招聘速度並提高員工流動性。這些應用不僅提高了效率，也重塑了整個醫療生態系統中信任的建立和維護方式。隨著越來越多的醫療機構採用可互通的區塊鏈平台，該技術將從小眾使用案例發展到企業級整合，預示著一個更具協作性、以患者為中心、資料安全的未來。

監管框架和產業合作將如何影響區塊鏈的採用？

區塊鏈在醫療保健領域的應用將深受法律規範、跨部門協作以及實現互通性和信任的技術標準的建立的影響。作為一個受到嚴格監管的行業，醫療保健必須確保區塊鏈的實施符合嚴格的法律要求，例如美國的《健康保險流通與責任法》(HIPAA)、歐洲的《一般資料保護規範》(GDPR) 以及其他地區的資料保護法。遵守這些法規需要精心設計區塊鏈架構，以支援隱私設計、選擇性資料存取和被遺忘權等功能。為了克服這些複雜性，像突觸健康聯盟(Synaptic Health 休閒) 和 Mediledger計劃這樣的產業聯盟正在興起，它們將保險公司、醫療服務提供者、科技公司和監管機構聚集在一起，共同開發符合合規標準並最大限度促進創新的區塊鏈框架。協作對於創建通用的資料交換和系統互通性通訊協定也至關重要，而這一直是大規模部署的主要障礙。 HL7 和 IEEE 等標準開發組織正在努力將區塊鏈納入現有的醫療保健互通性框架，例如 FHIR（快速醫療保健互通性資源）。政府資助和沙盒計畫正在進一步加速區塊鏈在醫療保健領域的實驗，有助於降低風險並檢驗投資報酬率。跨競爭邊界的相關人員參與將在區塊鏈從試點階段快速邁向廣泛應用方面發揮關鍵作用。在此背景下，監管透明度、相關人員協作以及擴充性的技術標準正成為決定區塊鏈融入主流醫療保健業務的速度和範圍的關鍵推動因素。

推動醫療保健市場區塊鏈成長的關鍵因素有哪些？

醫療保健領域區塊鏈市場的成長受到多種因素的驅動，這些因素源於技術進步、行業優先事項的轉變以及對數據透明度和安全性日益成長的需求。首先，從電子健康記錄 (EHR) 和遠端監控設備到基因組資料庫，數位健康數據的爆炸性成長需要強大的防篡改儲存、共用和存取管理系統。其次，資料外洩和醫療詐騙的增多，促使醫療機構尋求比傳統IT基礎設施更安全的替代方案，而區塊鏈提供了即時追蹤和加密保護措施，可提高審核和可靠性。此外，以多職業護理協調、遠端醫療的擴展和全球供應鏈為代表的醫療保健服務日益複雜，這要求採用區塊鏈支援的去中心化資料管理方法。例如，製藥公司擴大採用區塊鏈來確保藥品生產和分銷的透明度和可追溯性，尤其是在全球供應鏈中斷之後。另一個主要促進因素是向基於價值觀的醫療保健和以患者為中心的模式的轉變，這需要透明的數據流和檢驗的患者治療結果。創業投資和企業對區塊鏈醫療新興企業的研發也加速了創新和部署，尤其是在美國、歐洲和亞太等市場。最後，病人的期望也在不斷變化，越來越多的個人要求掌控自己的健康資訊及其使用方式，這促使醫療服務提供者和支付方採用賦予病人更多自主權的解決方案。這些因素共同為區塊鏈技術在醫療保健領域的應用創造了肥沃的土壤，使其轉變為更安全、更有效率、更基於信任的系統。

部分

網路（專用網路、公用網路）、最終用途（生物製藥和醫療設備公司、供應商、付款人）、應用（供應鏈管理應用、臨床試驗應用、臨床資料交換應用）

受訪公司範例（值得關注的36家公司）

  • Accenture Plc
  • Akiri
  • Avaneer Health
  • Blockchain Labs
  • Briya
  • BurstIQ
  • Change Healthcare
  • Chronicled
  • Doc.ai
  • Embleema
  • EncrypGen
  • FarmaTrust
  • Gem
  • Guardtime
  • IBM Corporation
  • iSolve LLC
  • Medicalchain
  • Microsoft Corporation
  • Nebula Genomics
  • Patientory Inc.

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP36398

Global Blockchain in Healthcare Market to Reach US$13.0 Billion by 2030

The global market for Blockchain in Healthcare estimated at US$1.2 Billion in the year 2024, is expected to reach US$13.0 Billion by 2030, growing at a CAGR of 49.0% over the analysis period 2024-2030. Private Network, one of the segments analyzed in the report, is expected to record a 51.8% CAGR and reach US$10.4 Billion by the end of the analysis period. Growth in the Public Network segment is estimated at 40.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$312.2 Million While China is Forecast to Grow at 46.2% CAGR

The Blockchain in Healthcare market in the U.S. is estimated at US$312.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 46.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 44.9% and 41.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 33.2% CAGR.

Global Blockchain in Healthcare Market - Key Trends & Drivers Summarized

Why Is Blockchain Emerging as a Foundational Technology in Healthcare Innovation?

Blockchain technology is rapidly being embraced as a transformative force in healthcare, promising to address some of the most persistent challenges in the industry such as data fragmentation, security vulnerabilities, and inefficiencies in administrative processes. At its core, blockchain provides a decentralized, immutable ledger that enables secure and transparent data sharing across diverse healthcare stakeholders. This unique capability is particularly important in an environment where patient records, insurance claims, clinical trials, and supply chain data are typically siloed and difficult to reconcile. By enabling real-time access to tamper-proof information, blockchain enhances data integrity and facilitates interoperability between systems that traditionally have lacked seamless integration. The heightened need for cybersecurity and privacy in handling electronic health records (EHRs) is another major driver, with blockchain offering end-to-end encryption and verifiable access control that exceed current standards. As digital health services grow-driven by telemedicine, wearables, and health apps-blockchain presents a solution for managing the surge in sensitive health data being generated and shared across devices. Moreover, governments and regulatory bodies are increasingly recognizing the technology’s potential, with several pilot programs and public-private partnerships being launched globally to test blockchain-based applications in health record management, drug traceability, and consent handling. As trust and transparency become critical pillars in healthcare transformation, blockchain is positioning itself not merely as an IT enhancement but as a foundational enabler of a new era in healthcare delivery.

How Are Blockchain Applications Evolving Across Different Healthcare Segments?

The scope of blockchain in healthcare is expanding rapidly, with applications emerging across multiple segments including patient data management, pharmaceutical supply chains, clinical trials, insurance, and provider credentialing. In the realm of patient records, blockchain facilitates the creation of longitudinal health records that patients can own, control, and share securely with multiple providers. This is particularly valuable in managing chronic diseases and coordinating care across specialties and geographic regions. In the pharmaceutical industry, blockchain is being deployed to combat counterfeit drugs by enabling end-to-end traceability of medications from manufacturer to pharmacy. Such transparency ensures authenticity, reduces fraud, and enhances drug recall efficiency. Similarly, blockchain is improving the integrity of clinical trials by providing immutable timestamped data for protocols, patient consent, and trial results-ensuring regulatory compliance and minimizing the risk of data manipulation. In insurance, smart contracts are streamlining claims adjudication, automating approvals and payments while reducing fraud and administrative costs. Meanwhile, healthcare organizations are beginning to use blockchain to validate provider credentials and licensure in real-time, speeding up hiring and improving workforce mobility. These applications are not only improving efficiency but are also reshaping how trust is built and maintained across the healthcare ecosystem. As more healthcare entities adopt interoperable blockchain platforms, the technology is evolving from niche use cases to enterprise-wide integration, heralding a more collaborative, patient-centric, and data-secure future.

How Do Regulatory Frameworks and Industry Collaboration Influence Blockchain Adoption?

The adoption of blockchain in healthcare is deeply influenced by regulatory frameworks, cross-sector collaboration, and the establishment of technical standards that enable interoperability and trust. As a highly regulated industry, healthcare must ensure that blockchain implementations comply with strict legal requirements such as HIPAA in the U.S., GDPR in Europe, and other regional data protection laws. These regulations necessitate careful design of blockchain architectures that can support privacy by design, selective data access, and right-to-be-forgotten functionalities-capabilities that challenge the traditionally immutable nature of blockchain. To navigate these complexities, industry consortia such as the Synaptic Health Alliance and the MediLedger Project are emerging, bringing together insurers, providers, technology firms, and regulatory bodies to co-develop blockchain frameworks that meet compliance standards while maximizing innovation. Collaboration is also essential in creating common protocols for data exchange and system interoperability, which remain key barriers to large-scale deployment. Standards development organizations like HL7 and IEEE are working on incorporating blockchain into existing healthcare interoperability frameworks such as FHIR (Fast Healthcare Interoperability Resources). Government funding and sandbox initiatives are further accelerating blockchain experimentation in healthcare, helping mitigate risk and validate ROI. The ability of stakeholders to work collectively-across competitive boundaries-will largely determine how quickly blockchain can move from pilots to widespread adoption. In this context, regulatory clarity, stakeholder alignment, and scalable technical standards are becoming critical enablers that will shape the pace and scope of blockchain integration into mainstream healthcare operations.

What Key Factors Are Driving Growth in the Blockchain in Healthcare Market?

The growth in the blockchain in healthcare market is driven by several factors rooted in technology advancements, shifting industry priorities, and growing demand for data transparency and security. First and foremost, the explosion of digital health data-from EHRs and remote monitoring devices to genomic databases-requires robust, tamper-proof systems for storage, sharing, and access management, a need that blockchain is uniquely positioned to fulfill. Second, the rising incidence of data breaches and healthcare fraud is pushing institutions to seek more secure alternatives to traditional IT infrastructure, with blockchain offering real-time tracking and cryptographic safeguards that enhance auditability and trust. Additionally, the growing complexity of healthcare delivery-marked by multi-provider care coordination, telemedicine expansion, and global supply chains-demands a decentralized approach to data management that blockchain enables. Pharmaceutical companies, for example, are increasingly adopting blockchain to ensure transparency and traceability in drug manufacturing and distribution, especially in the wake of global supply chain disruptions. Another significant driver is the shift toward value-based care and patient-centric models, which require transparent data flows and verifiable patient outcomes-functions that blockchain can support through smart contracts and immutable patient records. Venture capital investment and corporate R&D in blockchain healthcare startups are also accelerating innovation and deployment, particularly in markets such as the U.S., Europe, and Asia-Pacific. Finally, patient expectations are evolving, with more individuals demanding control over their health information and how it is used, prompting providers and payers to adopt solutions that empower patient agency. Together, these factors are creating a fertile environment for blockchain technologies to take root in healthcare, transforming it into a more secure, efficient, and trust-based system.

SCOPE OF STUDY:

The report analyzes the Blockchain in Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Network (Private Network, Public Network); End-Use (Biopharma & Medical Device Companies End-Use, Providers End-Use, Payers End-Use); Application (Supply Chain Management Application, Clinical Trials Application, Clinical Data Exchange Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • Accenture Plc
  • Akiri
  • Avaneer Health
  • Blockchain Labs
  • Briya
  • BurstIQ
  • Change Healthcare
  • Chronicled
  • Doc.ai
  • Embleema
  • EncrypGen
  • FarmaTrust
  • Gem
  • Guardtime
  • IBM Corporation
  • iSolve LLC
  • Medicalchain
  • Microsoft Corporation
  • Nebula Genomics
  • Patientory Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Blockchain in Healthcare - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Focus on Data Security and Patient Privacy Throws the Spotlight on Blockchain Solutions in Healthcare
    • Rising Incidence of Cyberattacks Spurs Demand for Immutable and Decentralized Record-Keeping Systems
    • Here's How Blockchain Is Reshaping Electronic Health Record Sharing Across Multi-Stakeholder Networks
    • Push for Interoperability and Real-Time Access Fuels Blockchain Adoption in Health Information Exchange
    • Here's the Story: How Smart Contracts Are Streamlining Provider Payments and Clinical Trial Agreements
    • Growth in Digital Health Ecosystems Supports Blockchain-Based Identity and Consent Management Tools
    • Cross-Border Health Data Transfer and Medical Tourism Drive Demand for Blockchain-Enabled Credentialing
    • Public Health and Pandemic Response Platforms Explore Blockchain for Secure and Verified Data Sharing
    • Investment from Tech Giants and Startups Accelerates Innovation in Blockchain Healthcare Infrastructure
    • Lack of Technical Standards, Interoperability, and Industry Alignment Pose Adoption Challenges
    • Blockchain Integration with AI and IoMT Enhances Predictive Healthcare and Remote Monitoring Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Blockchain in Healthcare Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Blockchain in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Blockchain in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Blockchain in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Private Network by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Private Network by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Private Network by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Public Network by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Public Network by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Public Network by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Biopharma & Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Biopharma & Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Biopharma & Medical Device Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Providers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Payers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Supply Chain Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Supply Chain Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Supply Chain Management Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinical Trials Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Clinical Trials Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Clinical Trials Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinical Data Exchange Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinical Data Exchange Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Clinical Data Exchange Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • JAPAN
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • CHINA
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: China 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: China 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: China 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • EUROPE
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Blockchain in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Blockchain in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • FRANCE
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: France 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: France 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: France 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • GERMANY
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • REST OF WORLD
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of World 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030

IV. COMPETITION